Guangxi Wonder Pharmaceutical Co., Ltd. is owned by Jiangxi Ganliang Pharmaceutical Materials Co., Ltd and founded in 2005. Our facility is built upon beautiful south costal area of China, the province of Guangxi. Ganliang and its fellow investors have invested more than 20million RMB to establish this world class API plant on its 27 hectares land, which including three combined workshops, a GMP refining-drying-packing workshop, a fermentation workshop and a R&D laboratory. This facility is served by 200 employees, with a team of more than 40 technicists in R&D. In addition to Drug Manufacture License(Gui 20160076) in 2011, Wonder Pharma also gets GMP license in 2012 and 2017.  

      Wonder Pharma is approved for four patent of invention, and focusing on steroid and hormones, starting from Diosesgenin, Tigogenin and Phytosterols. Our capacity for 19-Nor series, Progesterone, Dexamethasone and Betamethasone could reach respectively 60t/year, 80t/year, 10t/year and 10t/year, While our main products are Estra-4,9-diene-3,17-dione, Norandrostenedione, Estradiene dione-3-keta, Mifepristone and intermediates, Ulipristal and intermediates, Progesterone and intermediates, 11alpha-hydroxy canrenone, Dexamethasone and Betamethasone.

     Being integrated with Ganliang, Wonder Pharma is now turned into a new page, and looking forward to continue partnership with old friends as well as establishing rapports with new mates.